Concord Drugs Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Public

  • Employees
  • 250

Employees

  • Stock Symbol
  • 538965

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.76
  • (As of Friday Closing)

Concord Drugs General Information

Description

Concord Drugs Ltd is an India-based pharmaceutical company. The principal activity of the company is to manufacture licensed drugs based on approved formulations. Its product portfolio includes Pharmaceutical Ready-to-fill Pellets, MUPS (Multiple Unit Pellets System); Tissue Bio Adhesive; Injectables (Small Volume Parenterals); Capsules; Liquid Orals (Syrups & Suspensions); Dry Syrups (Powder); and Hand Sanitizers, among others.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Survey Number 249, Brahmanapally Village
  • Hayathnagar Mandal, Ranga Reddy District
  • Hyderabad, Telangana 501511
  • India
+91 090527
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
BOM
Corporate Office
  • Survey Number 249, Brahmanapally Village
  • Hayathnagar Mandal, Ranga Reddy District
  • Hyderabad, Telangana 501511
  • India
+91 090527

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Concord Drugs Stock Performance

As of 13-Nov-2026, Concord Drugs’s stock price is $0.76. Its current market cap is $10M with 13.2M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.76 $0.78 $0.63 - $1.02 $10M 13.2M 4.42K $0.02

Concord Drugs Financials Summary

As of 30-Jun-2026, Concord Drugs has a trailing 12-month revenue of $9.5M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 12,265 11,514 5,820 6,223
Revenue 9,498 8,911 5,351 5,427
EBITDA 643 504 485 488
Net Income 226 119 40 57
Total Assets 7,937 7,615 7,052
Total Debt 0 1,538 2,250 2,101
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Concord Drugs Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Concord Drugs‘s full profile, request access.

Request a free trial

Concord Drugs Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Concord Drugs Ltd is an India-based pharmaceutical company. The principal activity of the company is to manufacture lice
Drug Discovery
Hyderabad, India
250 As of 2026

Mumbai, India
 

Basel, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Concord Drugs Competitors (3)

One of Concord Drugs’s 3 competitors is Cipla, a Corporation company based in Mumbai, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cipla Corporation Mumbai, India
Novartis Corporation Basel, Switzerland
Torrent Pharmaceuticals Corporation Ahmedabad, India
You’re viewing 3 of 3 competitors. Get the full list »

Concord Drugs Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Concord Drugs Acquisitions (1)

Concord Drugs’s most recent deal was a Merger/Acquisition with Proton Remedies. The deal was made on 08-Sep-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Proton Remedies 08-Sep-2022 Merger/Acquisition Multi-line Chemicals
To view Concord Drugs’s complete acquisitions history, request access »

Concord Drugs ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Concord Drugs’s complete esg history, request access »

Concord Drugs FAQs

  • When was Concord Drugs founded?

    Concord Drugs was founded in 1995.

  • Where is Concord Drugs headquartered?

    Concord Drugs is headquartered in Hyderabad, India.

  • What is the size of Concord Drugs?

    Concord Drugs has 250 total employees.

  • What industry is Concord Drugs in?

    Concord Drugs’s primary industry is Drug Discovery.

  • Is Concord Drugs a private or public company?

    Concord Drugs is a Public company.

  • What is Concord Drugs’s stock symbol?

    The ticker symbol for Concord Drugs is 538965.

  • What is the current stock price of Concord Drugs?

    As of 13-Nov-2026 the stock price of Concord Drugs is $0.76.

  • What is the current market cap of Concord Drugs?

    The current market capitalization of Concord Drugs is $10M.

  • What is Concord Drugs’s current revenue?

    The trailing twelve month revenue for Concord Drugs is $9.5M.

  • Who are Concord Drugs’s competitors?

    Cipla, Novartis, and Torrent Pharmaceuticals are competitors of Concord Drugs.

  • What is Concord Drugs’s annual earnings per share (EPS)?

    Concord Drugs’s EPS for 12 months was $0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process